Matches in SemOpenAlex for { <https://semopenalex.org/work/W2256721603> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2256721603 endingPage "3470" @default.
- W2256721603 startingPage "3468" @default.
- W2256721603 abstract "This scientific commentary refers to ‘c-Myc–miR-29c–REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma’ by Luo et al. (doi:10.1093/brain/awv287) The emergence of tumour cell resistance to chemotherapy represents a major challenge for the development of durable therapeutic strategies across most solid cancers including glioblastoma, the most malignant primary brain tumour in adults. The standard of care for glioblastoma is maximum surgery as safely feasible followed by radiotherapy, with concomitant and maintenance chemotherapy with the alkylating agent temozolomide (TMZ/RT→TMZ). This results in a median overall survival in the range of 12 months on a population level (Weller et al. , 2014). Radiotherapy alone doubled median survival in early studies, but the best radiological response is commonly stable disease, progression is inevitable, and the efficacy of radiotherapy may be partly related to anti-angiogenic rather than intrinsic tumour cell cytotoxic effects. Mechanisms underlying resistance to radiotherapy remain poorly understood, but extensive hypoxia may be an important factor.TMZ was approved for the treatment of newly diagnosed glioblastoma because of a moderate prolongation of median survival (Stupp et al. , 2005). Subgroup analyses revealed that the benefit from TMZ was largely restricted to patients with glioblastomas that exhibit a particular epigenetic alteration, promoter methylation of the O6-methylguanine DNA methyltransferase ( MGMT ) gene (Hegi et al. , 2005). However, even these patients eventually all progress and succumb to their disease, in the absence of changes in MGMT promoter methylation …" @default.
- W2256721603 created "2016-06-24" @default.
- W2256721603 creator A5005843202 @default.
- W2256721603 creator A5017177249 @default.
- W2256721603 date "2015-11-23" @default.
- W2256721603 modified "2023-09-23" @default.
- W2256721603 title "New insights into acquired temozolomide resistance in glioblastoma?" @default.
- W2256721603 cites W1975104842 @default.
- W2256721603 cites W2096287682 @default.
- W2256721603 cites W2105100844 @default.
- W2256721603 cites W2121401234 @default.
- W2256721603 cites W2126764080 @default.
- W2256721603 cites W2159661815 @default.
- W2256721603 cites W2172431577 @default.
- W2256721603 cites W2313376391 @default.
- W2256721603 doi "https://doi.org/10.1093/brain/awv301" @default.
- W2256721603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26598490" @default.
- W2256721603 hasPublicationYear "2015" @default.
- W2256721603 type Work @default.
- W2256721603 sameAs 2256721603 @default.
- W2256721603 citedByCount "5" @default.
- W2256721603 countsByYear W22567216032018 @default.
- W2256721603 countsByYear W22567216032019 @default.
- W2256721603 countsByYear W22567216032021 @default.
- W2256721603 countsByYear W22567216032022 @default.
- W2256721603 crossrefType "journal-article" @default.
- W2256721603 hasAuthorship W2256721603A5005843202 @default.
- W2256721603 hasAuthorship W2256721603A5017177249 @default.
- W2256721603 hasBestOaLocation W22567216031 @default.
- W2256721603 hasConcept C15744967 @default.
- W2256721603 hasConcept C169760540 @default.
- W2256721603 hasConcept C18903297 @default.
- W2256721603 hasConcept C2776194525 @default.
- W2256721603 hasConcept C2777389519 @default.
- W2256721603 hasConcept C502942594 @default.
- W2256721603 hasConcept C57473165 @default.
- W2256721603 hasConcept C71924100 @default.
- W2256721603 hasConcept C86803240 @default.
- W2256721603 hasConceptScore W2256721603C15744967 @default.
- W2256721603 hasConceptScore W2256721603C169760540 @default.
- W2256721603 hasConceptScore W2256721603C18903297 @default.
- W2256721603 hasConceptScore W2256721603C2776194525 @default.
- W2256721603 hasConceptScore W2256721603C2777389519 @default.
- W2256721603 hasConceptScore W2256721603C502942594 @default.
- W2256721603 hasConceptScore W2256721603C57473165 @default.
- W2256721603 hasConceptScore W2256721603C71924100 @default.
- W2256721603 hasConceptScore W2256721603C86803240 @default.
- W2256721603 hasIssue "12" @default.
- W2256721603 hasLocation W22567216031 @default.
- W2256721603 hasLocation W22567216032 @default.
- W2256721603 hasLocation W22567216033 @default.
- W2256721603 hasLocation W22567216034 @default.
- W2256721603 hasLocation W22567216035 @default.
- W2256721603 hasOpenAccess W2256721603 @default.
- W2256721603 hasPrimaryLocation W22567216031 @default.
- W2256721603 hasRelatedWork W1817337096 @default.
- W2256721603 hasRelatedWork W1989074412 @default.
- W2256721603 hasRelatedWork W2075818092 @default.
- W2256721603 hasRelatedWork W2327167815 @default.
- W2256721603 hasRelatedWork W2474930342 @default.
- W2256721603 hasRelatedWork W2803617006 @default.
- W2256721603 hasRelatedWork W2808769567 @default.
- W2256721603 hasRelatedWork W2899665700 @default.
- W2256721603 hasRelatedWork W3139389455 @default.
- W2256721603 hasRelatedWork W606085651 @default.
- W2256721603 hasVolume "138" @default.
- W2256721603 isParatext "false" @default.
- W2256721603 isRetracted "false" @default.
- W2256721603 magId "2256721603" @default.
- W2256721603 workType "article" @default.